bioassay/AID489013

Predicate	Object
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/The_Scripps_Research_Institute_Molecular_Screening_Center
title	Counterscreen for procaspase-3 activators: absorbance-based biochemical high throughput dose response assay for activators of procaspase-7
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID489013
has assay stage	http://www.bioassayontology.org/bao#BAO_0000030
is confirmatory assay of	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID463210 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504814 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504816 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504822 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504824 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID488941 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID463141 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID488954 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID493114 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504328 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID493115 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504330 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID463197
type	http://www.bioassayontology.org/bao#BAO_0000015

Predicate	Subject
is confirmatory assay of	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504814 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504822 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504824 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504330 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504816 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID504328
is primary assay of	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID488954 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID463141 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID463210 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID488941 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID493114 http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID493115
is summary assay of	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID463197

Total number of triples: 31.